XWEL.NASDAQXwell, INC

DEF: XWELL, Inc. Seeks Stockholder Approval for Share Issuance, Board Classification, and Equity Plan Amendment

Sentiment:

Proxy Statement


XWELL, Inc. is convening a special meeting of stockholders to vote on proposals including authorizing share issuance related to a recent securities purchase agreement, classifying the board of directors, amending the equity incentive plan, ratifying the auditor, and adjourning the meeting if necessary.

Capital raiseOn January 14, 2025, XWELL entered into a Securities Purchase Agreement with certain accredited investors, pursuant to which it agreed to sell an aggregate of 4,000 shares of Series G Preferred Stock, Series A warrants to acquire up to an aggregate of 2,673,797 shares of Common Stock, and Series B warrants to acquire up to an aggregate of 2,673,797 shares of Common Stock.The closing of the Private Placement occurred on January 14, 2025, and XWELL received total gross proceeds of approximately $4 million.The company is seeking stockholder approval for the issuance of the Underlying Shares.

Summary

  • XWELL, Inc. is holding a special meeting on April 10, 2025, to seek stockholder approval for several key proposals.
  • The first proposal involves authorizing the issuance of common stock underlying Series G preferred stock and warrants, potentially exceeding 20% of the outstanding common stock prior to the issuance, to comply with Nasdaq Listing Rule 5635(d).
  • The company entered into a Securities Purchase Agreement on January 14, 2025, raising approximately $4 million in gross proceeds.
  • The second proposal aims to classify the Board of Directors into two classes with staggered two-year terms.
  • The third proposal seeks to amend the 2020 Equity Incentive Plan to increase the number of shares reserved for issuance by 2,500,000 to a total of 3,125,000 and increase the maximum value of shares subject to awards granted to non-employee directors during a single fiscal year to $750,000.
  • The fourth proposal is to ratify the selection of CBIZ CPAs P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
  • The final proposal requests authorization to adjourn the Special Meeting if necessary to permit further solicitation of proxies.
  • The Board of Directors recommends voting FOR all proposals.

Sentiment

Score: 6

Explanation: The document is primarily informational, outlining proposals for stockholder vote. While the company expresses a positive outlook, the potential for dilution and other risks temper the overall sentiment.

Positives

  • The proposed share issuance aims to comply with Nasdaq listing rules.
  • The classification of the board is believed to assure the continuity and stability of the company's long-term policies.
  • The proposed amendment to the equity incentive plan is intended to attract, retain, and motivate key personnel.
  • The ratification of the auditor is a routine matter.

Negatives

  • The potential issuance of a significant number of shares could dilute existing stockholders' ownership.
  • The classification of the board may discourage some takeover bids.
  • If the Issuance Proposal is not approved, the company may need to delay, reduce or eliminate certain research and development programs or other operations, sell some or all of its assets or merge with another entity.

Risks

  • Failure to obtain stockholder approval for the share issuance could limit the company's ability to make amortization or dividend payments in shares, potentially straining cash resources.
  • The increased number of issued shares of Common Stock in connection with the Private Placement may have an incidental anti-takeover effect.
  • The potential issuance of Underlying Shares would result in an increase in the number of shares of Common Stock outstanding, and our stockholders will incur dilution of their percentage ownership to the extent that the Investors convert their Preferred Shares or exercise their Warrants, or additional shares, if any, of Common Stock are issued pursuant to the dividend and amortization terms of the Series G Preferred Stock.

Future Outlook

The company intends to make amortization and dividend payments due to holders of the Series G Preferred Stock in the form of Common Stock to the extent allowed under the Certificate of Designations and applicable law in order to preserve its cash resources.

Management Comments

  • Ezra T. Ernst, President and Chief Executive Officer, urges stockholders to submit their vote as soon as possible.
  • The Board of Directors recommends a vote FOR each of the Issuance Proposal, the Board Classification Proposal, the Plan Amendment Proposal, the Auditor Ratification Proposal and the Adjournment Proposal.

Industry Context

Many companies use equity incentive plans to attract and retain talent, and staggered boards are a common corporate governance structure.

Comparison to Industry Standards

  • The document does not provide enough information to make a detailed comparison to industry standards.
  • However, the use of equity incentive plans and staggered boards are common practices among publicly traded companies.
  • Comparable companies in the travel and wellness sector, such as Massage Envy or European Wax Center (though privately held), may offer similar equity-based compensation to attract and retain key personnel.
  • The specific terms of the Series G Preferred Stock and warrants would need to be compared to similar financing instruments used by other companies in comparable situations to assess their relative favorability.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board ClassificationProposal to amend the Amended and Restated Certificate of Incorporation to classify the Board of Directors into two classes, with the directors in each class to serve staggered two-year terms.Upon filing with the Delaware Secretary of StateA classified board may increase the amount of time required for a takeover bidder to obtain control of our company without the cooperation of our Board, even if the takeover bidder were to acquire a majority of the voting power of our outstanding common stock.

Related Party Transactions

  • Iroquois Capital Investment Group, LLC (ICIG), which beneficially owns more than 5% of our voting securities, and its affiliate Iroquois Master Fund Ltd. (IMF), participated in the Private Placement.

Stakeholder Impact

  • Approval of the proposals could impact shareholders through potential dilution and changes in corporate governance.
  • Employees may be affected by changes to the equity incentive plan.
  • The company's financial stability and future operations could be influenced by the outcome of the vote on the share issuance proposal.

Next Steps

  • Stockholders are urged to vote on the proposals outlined in the proxy statement.
  • The Special Meeting will be held on April 10, 2025, to vote on the proposals.
  • The company will file a Form 8-K to report the final voting results within four business days after the Special Meeting.

Key Dates

DateDescription
January 9, 2006Original Certificate of Incorporation filed under the name of Vringo, Inc.
May 5, 2016Name changed to FORM Holdings Corp.
January 5, 2018Name changed to XpresSpa Group, Inc.
September 17, 20202020 Equity Incentive Plan originally approved by the Board of Directors (the Effective Date).
October 28, 20202020 Equity Incentive Plan approved by stockholders.
May 4, 2020Friedman LLP engaged as independent registered public accounting firm.
September 30, 2021Friedman LLP selection ratified by stockholders at the 2021 annual meeting.
October 4, 2022Friedman LLP selection ratified by stockholders at the 2022 annual meeting.
October 4, 2022Marcum, LLP became auditors.
August 9, 20222020 Plan amended to increase the total number of shares of Common Stock for issuance under the 2020 Plan to 12,500,000 shares.
August 22, 2023Marcum LLP selection ratified by stockholders at the 2023 annual meeting.
September 20, 2024CBIZ CPAs P.C. selection ratified by stockholders at the 2024 annual meeting.
October 24, 2022Name changed to XWELL, Inc.
September 26, 2023Amended and Restated Certificate of Incorporation further amended.
September 28, 20231-for-20 reverse stock split of Common Stock.
August 9, 2024Schedule 13G filed by XWEL INV I, LLC.
August 13, 2024Schedule 13D/A filed by CPC Pain & Wellness SPV, LLC.
November 2024CBIZ acquired Marcum.
January 14, 2025Securities Purchase Agreement entered into with accredited investors; Private Placement closed.
February 1, 2025Commencement of Series G Preferred Stock redemption in six equal quarterly installments.
February 13, 2025Board unanimously approved and recommended that stockholders adopt and approve the Amendment to the Certificate of Incorporation.
February 13, 2025Board of Directors approved the Plan Amendment.
February 14, 2025Record date for the Special Meeting.
April 7, 2025Deadline to register to attend the Special Meeting.
April 9, 2025Internet and telephone voting facilities close at 11:59 p.m. Eastern Time.
April 10, 2025Special Meeting of Stockholders to be held at 11:00 a.m. Eastern Time.
April 23, 2025Deadline for stockholders to submit proposals for the 2025 Annual Meeting to be included in the proxy statement.
June 1, 2025Deadline for the company to hold a stockholder meeting to solicit affirmative vote for approval of the issuance of the Preferred Shares, the Conversion Shares, the Warrants and the Warrant Shares.
June 22, 2025Earliest date for receipt of stockholder nominations for director and other proposals for the 2025 Annual Meeting.
July 22, 2025Latest date for receipt of stockholder nominations for director and other proposals for the 2025 Annual Meeting; Deadline to comply with the universal proxy rules under the Exchange Act.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.